Skip to content

SOCI - Standing Committee

Social Affairs, Science and Technology

Past Session: Past Session:
41-1 41st Parliament, 1st Session (June 2, 2011 - September 13, 2013)
Select a different session
 

Proceedings of the Standing Senate Committee on
Social Affairs, Science and Technology

Issue 16 - Minutes of Proceedings - May 9, 2012

OTTAWA, Wednesday, May 9, 2012
(38)

[English]

The Standing Senate Committee on Social Affairs, Science and Technology met this day at 4:16 p.m., in room 2, Victoria Building, the Honourable Kelvin K. Ogilvie, Chair, presiding.

Members of the committee present: The Honourable Senators Callbeck, Cordy, Demers, Eggleton, P.C., Martin, Ogilvie, Rivard, Seidman, Verner, P.C., and Wallace (10).

In attendance: Sonya Norris, Analyst, Parliamentary Information and Research Service, Library of Parliament.

Also in attendance: The official reporters of the Senate.

Pursuant to the order of reference adopted by the Senate on Thursday, November 17, 2011, the committee continued its study on prescription pharmaceuticals in Canada. (For complete text of the order of reference, see proceedings of the committee, Issue No. 12.)

WITNESSES:

Canadian Medical Association:

Dr. Maura Ricketts, Director, Health Policy and Research;

Millicent Toombs, Senior Policy Analyst, Health Policy and Research.

As individuals:

Dr. Stuart MacLeod, Professor, Child and Family Institute, University of British Columbia;

Dr. Robin Walker, Integrated Vice-President, Medical Affairs and Education, London Health Sciences Centre and St Joseph's Health Care.

Association of Canadian Academic Healthcare Organizations:

Dr. David Hill, Co-chair, Vice-Presidents of Health Research Group;

Tina Saryeddine, Assistant Vice-President, Research and Policy Analysis.

The chair made a statement.

Dr. Hill, Dr. Walker, Dr. MacLeod and Dr. Ricketts each made a statement and, together with Ms. Toombs and Ms. Saryeddine, answered questions.

DECLARATIONS OF PRIVATE INTERESTS

Pursuant to subsection 12(1) of the Conflict of Interest Code for Senators, a declaration of private interests was made as follows:

— By written declaration, the Honourable Senator Merchant (special study on prescription pharmaceuticals in Canada).

At 6 p.m., the committee adjourned to the call of the chair.

ATTEST:

 

Jessica Richardson

Clerk of the Committee

Back to top